CTRI/2022/12/047860尚未招募3 期
A prospective, randomized, open-label, active-controlled, clinical study to evaluate the tolerability and incidence of pregnancy complications up on Lipocal supplementation in pregnant women
G.C Chemie Pharmie Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Pregnant females between the ages of >=18 and 40 years (both inclusive) willing to participate in study and provide written informed consent.
- •2. Pregnant women at 20th weeks attending antenatal care visit (ANC) visit at study clinics.
排除标准
- •1. No medical contraindications to continuing pregnancy.
- •2. Treatment with antitubercular and anti-epileptic drugs.
- •3. History of pre-eclampsia & eclampsia
- •4. History or signs and/or symptoms of nephrolithiasis
- •5. Prior diagnosis of parathyroid disorder or thyroidectomy
- •6. Diseases that require digoxin, phenytoin, or tetracycline therapy
- •7. History of chronic liver disease
- •8. History of renal disease & no known uterine anomaly
- •9. No history of cervical conization
- •10. Obesity (BMI 30.0 and higher)
- •11. Diagnostic history of Type I & Type II Diabetes
- •12. Diagnostic history of hypertension
- •13. History of any autoimmune disease
- •14. Subject with multiple pregnancy.
- •15. Diagnostic history of fetal anomalies.
- •16. Any other condition that in the opinion of the
- •investigator does not justify the patients participation in the study.
研究者
相似试验
进行中（未招募）
不适用
A prospective, randomized, open-label, active-controlled study in adult subjects with acute bacterial sinusitis comparing the clinical efficacy of telithromycin (KETEK®) 800 mg once a day for 5 days versus amoxicillin-clavulanic acid (AUGMENTIN®) 875/125 mg twice a day for 10 days.acute bacterial sinusitis (ABS)MedDRA version: 7.0Level: LLTClassification code 10000858EUCTR2004-001460-42-DEAventis Intercontinental - Sanofi-aventis298
已完成
4 期
post-marketing study to evaluate the efficacy and safety of (silodosin) vs Tamsulosin in Indian male patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.CTRI/2019/12/022231Sun Pharma Industries Ltd246
已完成
不适用
A prospective, open label, randomized, active control, parallel design, comparative pharmacokinetics study of Intramuscular Pegaspargase (Hamsyl) of Gennova Biopharmaceuticals Ltd versus Intramuscular Oncaspar® in pediatric patients with relapsed cases of Acute Lymphoblastic Leukemia (ALL)CTRI/2016/02/006589Gennova Biopharmaceuticals Ltd29
进行中（未招募）
3 期
Trial to evaluate singlebooster dose of ZyCoV-D of M/s ZydusLifesciences Limited in adult subjects alreadyvaccinated with 2 doses of Covaxin or CovishieldCTRI/2022/06/043365Zydus Lifesciences Limited576
招募中
2 期
Comparison of efficacy of Indomethacin vs Paracetamol along with standard care of treatment in mild and moderate Covid-19 patientsCTRI/2021/05/033544IIT Madras